Welcome to This Week in Pediatrics. This week we are covering ten notable papers spanning neonatal and early-life interventions, pediatric therapeutic safety, and adolescent mental health and chronic care. We will explore how common therapies like paracetamol and anesthesia might affect long-term development, examine the real-world performance of biologic biosimilars, and dissect how environmental…

This week's papers:

Paracetamol as analgesic and risk of bronchopulmonary dysplasia in extremely preterm infants: a secondary analysis of the BeNeDuctus trial. — Pediatric research 2026
Paediatric anaesthesia and the developing brain. — The Lancet. Child & adolescent health 2026
Community Firearm Violence, Youth Depression, and Suicide Risk in Philadelphia: 2017-2024. — Pediatrics 2026
Opportunities for Pediatricians to Address Racism and Bias to Reduce Racial Disparities in Breastfeeding and the Use of Human Milk: Policy Statement. — Pediatrics 2026
Gastrointestinal Adverse Events Following Rotavirus Vaccination in Children: A Systematic Review. — Acta paediatrica 2026
Maternal vitamin D status modifies the association between GDM and offspring neurodevelopment: a prospective birth cohort study. — Pediatric research 2026
Influence of probiotics on faecal antibiotic resistome in neonates: a systematic review. — Pediatric research 2026
Infliximab originator and biosimilars have similar efficacy in children with inflammatory bowel disease. — Journal of pediatric gastroenterology and nutrition 2026
Screening of pre-type 1 diabetes in high-risk paediatric population: a pilot study in Latvia. — European journal of pediatrics 2026
Health complaints, social impacts, and perceived care effectiveness reported by children with obesity and their parents: a prospective observational study in the Obesity Center CGG cohort. — European journal of pediatrics 2026